Acute-phase reactants (ESR and CRP) can provide some indication of disease activity and extent of damage, serving as reference markers to help distinguish drug-induced liver injury from disease relapse,[19,20] concurrently, vigilance for infections and other inflammatory conditions is essential. This evidence concerns the gene CRP and infection.